Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus
Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 9c, Revenues Miss; Offers FY20 Revenue Guidance Above Consensus| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 14.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.41 | 52 Week High | $12.48 | |||
| Open | $14.41 | 52 Week Low | $1.60 | |||
| Day High | $14.41 | P/E | N/A | |||
| Day Low | $14.41 | EPS | $-6.33 | |||
| Volume | 705 | |||||

